Vericel (VCEL) Share-based Compensation Growth (5y) (2015 - 2026)
Vericel (VCEL) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Vericel |
2.04 Bn |
1.90 Bn |
49.27 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
9.98% |
| Dec 31, 2025 |
22.74% |
| Sep 30, 2025 |
26.60% |
| Jun 30, 2025 |
18.30% |
| Mar 31, 2025 |
25.01% |
| Dec 31, 2024 |
20.75% |
| Sep 30, 2024 |
22.94% |
| Jun 30, 2024 |
17.88% |
| Mar 31, 2024 |
30.20% |
| Dec 31, 2023 |
36.02% |
| Sep 30, 2023 |
32.61% |
| Jun 30, 2023 |
28.87% |
| Mar 31, 2023 |
45.43% |
| Dec 31, 2022 |
65.31% |
| Sep 30, 2022 |
64.53% |
| Jun 30, 2022 |
68.49% |
| Mar 31, 2022 |
80.17% |
| Dec 31, 2021 |
71.66% |
| Sep 30, 2021 |
67.40% |
| Jun 30, 2021 |
67.22% |
